Imatinib plasma levels in patients with chronic myeloid leukaemia under routine clinical practice conditions.
Betel Del Rosario GarcíaIris González GarcíaMaría Micaela Viña RomeroJonathan González GarcíaRuth Tramontani RamosIvette Mourani PadrónSunil Lakhwani LakhwaniGloria Julia Nazco CasariegoFernando Gutiérrez NicolásPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
This study aimed to describe the correlation between the toxicity and effectiveness of imatinib according to its Cssmin in routine clinical practice conditions. Based on our findings, it would be certainly justified to monitor patient plasma concentrations of imatinib on a daily routine basis in our hospitals.